What other stocks do shareholders of Adynxx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adynxx investors own include Achillion Pharmaceuticals (ACHN) , ACADIA Pharmaceuticals (ACAD) , Arbutus Biopharma (ABUS) , Abacus Property Group (ABP) , Advanced BioMedical Technologies (ABMT) , Abiomed (ABMD) , ARCA biopharma (ABIO) , Abeona Therapeutics (ABEO) and Abcam (ABCZY) .

How do I buy shares of Adynxx?

Shares of ADYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ADYX

Adynxx (ADYX) Stock Price, News & Analysis

→ $25,000 into $109,616 in two months? (From WealthPress) (Ad)

Free ADYX Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials SEC Filings

Get Adynxx alerts:

Ad WealthPress

$25,000 into $109,616 in two months?

Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…

Go here to watch the most recent trading workshop video at no charge.

About Adynxx Stock (OTCMKTS:ADYX)

Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.

Ad WealthPress

$25,000 into $109,616 in two months?

Go here to watch the most recent trading workshop video at no charge.

ADYX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive ADYX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adynxx and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/24/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: OTCMKTS:ADYX
CUSIP: N/A
CIK: 1054274
Web: www.adynxx.com
Phone: (415) 512-7740
Fax: 215-702-8535
Employees: 6
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Richard Orr Esq. (Age 63)
J.D., President, CEO, Principal Financial Officer & Director
Comp: $473.59k
Dr. Julien Mamet Ph.D. (Age 48)
Founder, Chief Scientific Officer & Director
Comp: $378.47k
Mr. William Martin
Executive Vice President of Corporate Development & Operations
Ms. Dina Gonzalez
Principal Accounting Officer & Senior VP of Finance
Ms. Kimberley Hebert
Senior Director of Clinical Operations

Key Competitors

View All Competitors

ADYX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Adynxx own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Adynxx investors own include Achillion Pharmaceuticals (ACHN), ACADIA Pharmaceuticals (ACAD), Arbutus Biopharma (ABUS), Abacus Property Group (ABP), Advanced BioMedical Technologies (ABMT), Abiomed (ABMD), ARCA biopharma (ABIO), Abeona Therapeutics (ABEO) and Abcam (ABCZY).
How do I buy shares of Adynxx?: Shares of ADYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ADYX) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial